drugset / Trial / NCT03751969

A Study Evaluating the Mass Balance of Micro-dose[14C]HSK3486 Emulsion Injection in Healthy Adults

NCT03751969

NaSingle-groupOpen-labelTreatment

Summary

This study is designed to evaluate the mass balance in healthy Chinese male subjects after receiving a single dose of intravenous \[14C\]HSK3486, so as to assess the overall pharmacokinetics and safety of HSK3486 in humans and provide a reference for reasonable use of this drug.

Timeline

Start
2020-03-30
Primary completion
2020-11-01
Completion
2020-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule 0.4 mg/kg Intravenous

Indications

No indication recorded.